Gold-based cancer drug outperforms chemotherapy – researchers

Dale Arasa 12/08/2024

Researchers from the RMIT University in Australia and Indian institutions unveiled a gold-based cancer drug with promising potential. The medication slowed tumor growth in animals by 82 percent. Even better, it targeted cancer cells more effectively than…

Millennial midlife crisis: About ‘purpose and engagement’

Dale Arasa 11/12/2024

Some people mistake “millennials” for the youth when the eldest in that generation is now 43.  As a result, the public fails to recognize the growing millennial midlife crisis worldwide. People usually recognize the conventional midlife crisis…

Triphallia: Man with 3 genitalia discovered by researchers

Dale Arasa 10/16/2024

Did you ever know what Triphallia is?  Triphallia is a rare congenital anomaly where a person has three distinct penile shafts. It was highlighted lately when researchers discovered a man with three genitalia after he donated his…

China’s first-ever rhesus monkey clone survives three years

Dale Arasa 01/19/2024

China’s first cloned rhesus monkey lived for over two years, marking the longest-living rhesus macaque. In contrast, previous cloning attempts yielded specimens with no live births or with offspring dying within hours. The Chinese Academy of Sciences…

Your phone’s light sensor can spy on you

Dale Arasa 01/19/2024

MIT researchers discovered the dark side of smartphone light sensors; it can help hackers track your movements! Malicious individuals can use artificial intelligence models to reconstruct images of what’s happening in front of your screen. For example,…

NASA finds ‘Christmas Tree Cluster’ in space

Dale Arasa 12/26/2023

NASA took a photo of a group of stars resembling the shape of a Christmas tree. Special gases constituted the green pine needle-like shapes of the interstellar holiday symbol. Also, the stars served as the fairy lights…

Spanish AI Influencer earns more than $12,000 monthly

Dale Arasa 11/27/2023

A 25-year-old influencer has captured the world’s attention, captivating fans with her pink hair and perfect washboard abs. Yet, Aitana does not exist; she’s an artificial intelligence created by the Spain-based designer agency The Clueless. Founder Rubén…

World’s first tooth-growth drug created in Japan 

Dale Arasa 09/29/2023

The first-ever tooth-growth drug was created by a Japanese pharmaceutical company. It will undergo clinical trials next year so that it can meet its 2030 market release. The tooth-growth drug could help people with specific conditions speak…

Chinese scientists grow first-ever humanized kidneys in pigs

Dale Arasa 09/13/2023

Chinese scientists made a world record for growing the first-ever humanized kidneys in pigs. In other words, they have figured out how to create organs in pigs, potentially helping those who need transplants. We could use this…

Japan leads the way in clearing space debris

Dale Arasa 09/12/2023

A space rocket blazing a trail across the sky is a fantastic sight. Yet, as it drops its boosters, have you ever asked, “I wonder where that space debris will go?” Tokyo-based company Astroscale Japan Inc. will…

Japanese city uses robots to help anxious kids return to school

Dale Arasa 09/07/2023

The COVID pandemic had a disastrous effect on Japanese schools, raising the number of students not attending classes. In response, Kumamoto City proposed a unique solution: robots. It will launch a pair of robots enabling students to…

AI photo editor turns Asian MIT student white to make her look ‘more professional’

Dale Arasa 08/07/2023

An AI photo editor shocked an Asian MIT student after turning her into a Caucasian.  Rona Wang has been experimenting with AI prompts and image generators, but she never expected Playground AI to turn her into a…

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.